An overview of pharmaceutical cocrystals as intellectual property.
This review article focuses on the interaction among certain scientific, legal, and regulatory aspects of pharmaceutical crystal forms. The article offers an analysis of pharmaceutical cocrystals as patentable inventions by drawing upon recent scientific developments in the field. Several potential commercial advantages of pharmaceutical cocrystals are highlighted, and a number of recent court decisions involving salient issues are summarized. The article provides an outlook on how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.
Trask
Andrew V
AV
Jones Day, 222 East 41st Street, New York, New York 10017, USA. avtrask@jonesday.com
D003460:Crystallization; D004345:Drug Industry / Q000331:legislation & jurisprudence; D018973:Intellectual Property; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence; D010330:Patents as Topic; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D014481:United States
D004364:Pharmaceutical Preparations